Immunoreactivity for cyclin D1 is a reliable marker of gene aberration in plasma cell myeloma but does not specify patients prognosis.
Pruneri G, Alietti A, Agnelli L, Morabito F, Laszlo D, Calabrese L, Fabris S, Bertolini F, Agazzi A, Bottiglieri L, Raviele PR, Baldini L, Pileri S, Sabattini E, Bosari S, Maisonneuve P, Lambertenghi-Deliliers G, Bertoni F, Martinelli G, Viale G, Neri A.
Pruneri G, et al. Among authors: agazzi a.
Leuk Res. 2008 Oct;32(10):1628-32. doi: 10.1016/j.leukres.2008.02.002. Epub 2008 Mar 19.
Leuk Res. 2008.
PMID: 18355918
No abstract available.